In the same line, Chan et al. [86] reported a better performance for a biomarker panel consisting of CA125, CA19-9, and laminin subunit gamma 2 (LAMC2) than for CA19-9 alone in the detection of PC and even in the differentiation between early-stage PC and chronic pancreatitis. Here, LAMC2 is linked to pachyonychia congenita.